Where this thyroid cancer information comes from
On this page are the major sources of information that we use to put together this section of Cancer Research UK's patient information.
All our information is checked by cancer specialists and surgeons who specialise in treating cancer. The names of our specialist reviewers are at the end of this list. We also try to find patients to review all our sections. If you have had thyroid cancer, live in the UK and would like to become a patient reviewer, you can write to us by clicking on contact us.
Cancer principles and practice of oncology (9th edition)
De Vita VT, Lawrence TS and Rosenberg SA
Lippincott, Wiliams and Wilkins, 2011
Cancer and its management (6th edition)
J Tobias and D Hochhauser
AJCC Cancer Staging Manual (7th edition)
American Joint Committee on Cancer
Referral Guidelines for Suspected Cancer
The National Institute for Health and Care Excellence (NICE), June 2015
Link to the referral guidelines on the NICE website
Scottish referral guidelines for suspected cancer: Quick reference guide
The Scottish Government, March 2009
Link to the referral guidelines on the Scottish Government website
Guidelines for the management of thyroid cancer in adults
The Royal College of Physicians and British Thyroid Association, September 2007
Link to the British Thyroid Association website
Differentiated thyroid cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Pacini F, Castaggna MG, Brilli L and Pentheroudakis G on behalf of the ESMO Guidelines Working Group. Annals of Oncology. 2012. 23 (supplement 7):vii 110-119
2012 European Thyroid Association guidelines for metastatic medullary thyroid cancer. Schlumberger M, Bastholt L, Dralle H et al. The European Thyroid Association Task Force. European Thyroid Journal. 2012. 1: 5-14
British Thyroid Association Guidelines for the Management of Thyroid Cancer. Perros P, Colley S, Noelaert K, Evans RM, Gerrard GE, Gilbert JA, Harrison B, Johnson SJ, Giles TE, Moss L, Lewington V, Newbold KL, Taylor J, Thakker RV, Watkinson J, Williams GR. Clinical Endocrinology volume 81 July 2014
New approaches in the management of radioiodine-refractory thyroid cancer: the molecular targeted therapy era. J Capdevila, G Argiles, V Rodriguez-Frexinos, I Nuñez, J Tabernero. Discovery Medicine, 2010. Feb;9(45):153-62.
Complications of radioactive iodine treatment of thyroid carcinoma. Lee SL,The Journal of the National Comprehensive Cancer Network 2010 Nov 8(11);1277–86
Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma. V Rufini, P Castaldi, G Treglia, G Perotti, MD Gross, A Al-Nahhas, D Rubello. Biomedicine and Pharmacotherapy, 2008. Mar;62(3):139-46. Epub 2007 Aug 20.
Chemoembolization for liver metastases from medullary thyroid carcinoma. J Fromigué, T De Baere, E Baudin, C Dromain, S Leboulleux, M Schlumberger. Journal of Clinical Endocrinology and Metabolism, 2006. Jul;91(7):2496-9. Epub 2006 Apr 11.
Advances in the management of hereditary medullary thyroid cancer. Machens, A., Ukkat, J., Brauckhoff, M., Gimm, O. & Dralle, H.. Journal of Internal Medicine, (2005); 257: 50-59.
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. F Pacini, M Schlumberger, H Dralle, R Elisei, J Smit, W Wiersinga and the European Thyroid Cancer Taskforce. European Journal of Endocrinology (2006); 154: 787-803.
Is adjuvant therapy useful in patients with papillary carcinoma smaller than 2 cm? PW Rosário, MA Borges, MM Valadão, FP Vasconcelos, LL Rezende, EL Padrão, AL Barroso, S Purisch. Thyroid, 2007 Dec;17(12): 1225-8.
Controversies in primary treatment of low risk papillary thyroid cancer. McLeod DSA, Sawka AM and Cooper DS. The Lancet. 2013. vol 381: 1046-57
Progress in molecular based management of differentiated thyroid cancer. Xing M, Haugen BR, Schlumberger M. The Lancet 2013. vol 381: 1058-69
Dr Caroline Brammer, Consultant Clinical Oncologist
Mr Simon Smith, Consultant General Surgeon
Dee McLean – McDee Art, Medical Illustration
Question about cancer? Contact our information nurse team